Functional Activities Questionnaire, Czech Version – a Validation Study
Authors:
O. Bezdíček 1; J. Lukavský 2,3; M. Preiss 3
Authors‘ workplace:
Centrum klinických neurověd, Neurologická klinika 1. LF UK a VFN v Praze
1; Psychologický ústav AV ČR, Praha
2; Psychiatrické centrum Praha
3
Published in:
Cesk Slov Neurol N 2011; 74/107(1): 36-42
Category:
Original Paper
Overview
Objective:
This article describes the psychometric properties of Pfeffer’s Functional Activities Questionnaire (FAQ), in its Czech version, for measurement of the activities of daily living (ADL) in older persons without cognitive impairment.
Methods:
Pfeffer’s Functional Activities Questionnaire and the neuropsychological battery were administered to 136 older persons (test) at baseline (self-report). Eighty-two of these older persons were followed at 6-month intervals (retest) and they were also evaluated by their caregivers (informant report).
Results:
Neither age (self-report: r = 0.06; p = 0.50; informant report: r = 0.07; p = 0.57) nor education (self-report: r = 0.12; p = 0.18; informant report: r = –0.09; p = 0.49) had a significant influence on the FAQ results. Gender was statistically significant (self-report): t(35.33) = 2.848; p <0.01; informant report: t(18.13) = 2.332; p <0.05. The relation of FAQ to performance in the Mini-Mental State Exam (MMSE) was not significant. There is a statistically significant relation between FAQ and the neuropsychological battery (particularly auditory verbal learning test (AVLT) and shopping list, but with low correlations). Between FAQ test and retest after a 6-month interval, a statistically significant difference (t(81) = –1.356; p = 0.18) emerged. The difference between self report and informant report was also statistically significant (t(63) = 3.274; p <0.01). Test-retest reliability of the FAQ scale between the first measurement and 6-month retest was r = 0.56, p <0.001. Correlation between self-report and informant report was r = 0.64, p <0.001. Internal consistency in test-retest and informant report was 0.62; 0.79; 0.46 (based on Cronbach’s α).
Conclusions:
These findings indicate that FAQ is a valid and reliable instrument for the measurement of ADL in older persons without cognitive impairment. It is appropriate for the evaluation of functional deficit in older persons at possible risk of developing neurodegenerative disease.
Key words:
questionnaire – validity – activities of daily living – Alzheimer‘s disease
Sources
1. Bartoš A, Martínek P, Bezdíček O, Buček A, Řípová D. Dotazník funkčního stavu FAQ-CZ – česká verze pro zhodnocení každodenních aktivit pacientů s Alzheimerovou nemocí. Psychiat pro Praxi 2008; 9(1): 31–34.
2. Gauthier L, Gauthier S. Assessment of functional changes in Alzheimer’s disease. Neuroepidemiology 1990; 9(4): 183–188.
3. Folstein MF, Folstein SE, McHugh PR. „Mini-Mental State“. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12(3): 189–198.
4. Folstein MF, Folstein SE, McHugh PR. Mini-Mental® State Examination (MMSE™). Lutz, FL: Psychological Assessment Resources 2000.
5. World Health Organization. The ICD-10 Classificiation of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization 1995.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IV-TR), 4th ed. Washington, DC: American Psychiatric Association 2000.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34(7): 939–944.
8. Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31(12): 721–727.
9. Gauthier S, Gélinas I, Gauthier L. Functional disability in Alzheimer’s disease. Int Psychogeriatr 1997; 9 (Suppl 1): 163–165.
10. Stern Y, Hesdorffer D, Sano M, Mayeux R. Measurement and prediction of functional capacity in Alzheimer’s disease. Neurology 1990; 40(1): 8–14.
11. Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998; 46(4): 444–452.
12. Heyman A, Peterson B, Fillenbaum G, Pieper C. Predictors of time to institutionalization of patients with Alzheimer’s disease: the CERAD experience, part XVII. Neurology 1997; 48(5): 1304–1309.
13. Harwood DG, Barker WW, Ownby RL, Bravo M, Aguero H, Duara R. Predictors of positive and negative appraisal among Cuban American caregivers of Alzheimer’s disease patients. Int J Geriatr Psychiatry 2000; 15(6): 481–487.
14. Cullen JS, Grayson DA, Jorm AF. Clinical diagnoses and disability of cognitively impaired older persons as predictors of stress in their carers. Int J Geriatr Psychiatry 1997; 12(10): 1019–1028.
15. Teri L, Truax P. Assessment of depression in dementia patients: association of caregiver mood with depression ratings. Gerontologist 1994; 34(2): 231–234.
16. Zank S, Frank S. Family and professional caregivers’ ratings of dementia symptoms and activities of daily living of day care patients: do differences change over time? Aging Ment Health 2002; 6(2): 161–165.
17. Espiritu DA, Rashid H, Mast BT, Fitzgerald J, Steinberg J, Lichtenberg PA. Depression, cognitive impairment and function in Alzheimer’s disease. Int J Geriatr Psychiatry 2001; 16(11): 1098–1103.
18. Winblad B. Maintaining functional and behavioral abilities in Alzheimer disease. Alzheimer Dis Assoc Disord 2001; 15 (Suppl 1): S34–S40.
19. Gélinas I, Gauthier S, Cyrus PA. Metrifonate enhances the ability of Alzheimer’s disease patients to initiate, organize, and execute instrumental and basic activities of daily living. J Geriatr Psychiatry Neurol 2000; 13(1): 9–16.
20. Blesa R. Galantamine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord 2000; 11 (Suppl 1): 28–34.
21. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Geront 1982; 37(3): 323–329.
22. Bucks RS, Haworth J. Bristol Activities of Daily Living: a critical evaluation. Expert Rev Neurotherapeutics 2002; 2(5): 669–676.
23. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002; 58(5): 758–764.
24. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biol Psychiatry 2008; 64(10): 871–879.
25. Juva K, Mäkelä M, Erkinjuntti T, Sulkava R, Ylikoski R, Valvanne J et al. Functional assessment scales in detecting dementia. Age Aging 1997; 26(5): 393–400.
26. Gélinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther 1999; 53(5): 471–481.
27. Feldman H, Sauter A, Donald A, Gélinas I, Gauthier S, Torfs K et al. The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord 2001; 15(2): 89–95.
28. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25(2): 113–120.
29. Byrne LM, Wilson PM, Bucks RS, Hughes AO, Wilcock GK. The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer’s disease. Int J Geriatr Psychiatry 2000; 15(7): 656–661.
30. Bartoš A, Martínek P, Buček A, Řípová D. Dotazník soběstačnosti DAD-CZ – česká verze pro hodnocení každodenních aktivit pacientů s Alzheimerovou nemocí. Neurol pro praxi 2009; 10(5): 320–323.
31. Mejia S, Gutiérrez LM, Villa AR, Ostrosky-Solís F.Cognition, functional status, education, and the diagnosis of dementia and mild cognitive impairment in Spanish-speaking elderly. Appl Neuropsychol 2004; 11(4): 196–203.
32. Nitrini R, Caramelli P, Herrera E jr, Bahia VS, Caixeta LF, Radanovic M et al. Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2004; 18(4): 241–246.
33. Quiroga P, Albala C, Klaasen G. Validation of a screening test for age associated cognitive impairment, in Chile. Rev Med Chil 2004; 132(4): 467–478.
34. Nitrini R, Caramelli P, Bottino CM, Damasceno BP, Brucki SM, Anghinah R. Diagnosis of Alzheimer’s disease in Brazil: cognitive and functional evaluation. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Arq Neuropsiquiatr 2005; 63(3A): 720–727.
35. Laks J, Batista EM, Guilherme ER, Contino AL, Faria ME, Rodrigues CS et al. Prevalence of cognitive and functional impairment in community-dwelling elderly: importance of evaluating activities of daily living. Arq Neuropsiquiatr 2005; 63(2A): 207–212.
36. Herrera E jr, Caramelli P, Silveira AS, Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16(2): 103–108.
37. Ríos C, Pascual LF, Santos S, López E, Fernández T, Navas I et al. Working memory and complex activities of everyday life in the initial stages of Alzheimer’s disease. Rev Neurol 2001; 33(8): 719–722.
38. Tekin S, Fairbanks LA, O’Connor S, Rosenberg S, Cummings JL. Activities of daily living in Alzheimer’s disease: neuropsychiatric, cognitive, and medical illness influences. Am J Geriatr Psychiatry 2001; 9(1): 81–86.
39. McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N et al. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry 2006; 14(7): 582–588.
40. Stephens S, Kenny RA, Rowan E, Kalaria RN, Bradbury M, Pearce R et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. J Am Geriatr Soc 2005; 53(1): 103–107.
41. Bartoš A, Martínek P. Dotazník funkčního stavu FAQ-CZ. Dostupné z: http://www.pcp.lf3.cuni.cz/adcentrum/klinicka_cast/prolekare.html
42. Preiss M. Paměťový test učení. Bratislava: Psychodiagnostika 1999.
43. WMS-III. Technická příručka. Bratislava: Psychodiagnostika 1999.
44. Preiss M. Trail making test pro děti a dospělé. Manuál. Bratislava: Psychodiagnostika 1997.
45. Dragomirecka E, Lenderking WR, Motlova L, Goppoldova E, Selepova P. A brief mental health outcomes measure: Translation and validation of the Czech version of the Schwartz Outcomes Scale-10. Qual Life Res 2006; 15(2): 307–312.
46. Statistical Package for the Social Sciences 16.0. Chicago (Illinois): SPSS Inc. 2007.
47. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing 2009. Dostupné z URL: http://www.R-project.org.
48. Anastasi A, Urbina S. Psychological Testing. 7th ed. New York: Prentice Hall 1997.
49. Karagiozis H, Gray S, Sacco J, Shapiro M, Kawas C. The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living. Gerontologist 1998; 38(1): 113–121.
50. Ringman JM, Medina LD, Rodriguez-Agudelo Y, Chavez M, Lu P, Cummings JL. Current concepts of mild cognitive impairment and their applicability to persons at risk for familial Alzheimer’s disease. Curr Alzheimer Res 2009; 6(4): 341–346.
51. Sheardová K, Hort J, Rusina R, Bartoš A, Línek V, Ressner P et al. Doporučené postupy pro léčbu Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Cesk Slov Neurol N 2007; 70/103(5): 589–594.
52. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a ostatních demencí. Neurol pro praxi 2009; 10(4): 237–241.
53. Petersen RC. Early diagnosis of Alzheimer’s disease: is MCI too late? Curr Alzheimer Res 2009; 6(4): 324–330.
54. Bartoš A, Martínek P, Řípová D. Dotazník Bristolská škála aktivit denního života BADLS-CZ pro hodnocení pacientů s demencí. Cesk Slov Neurol N 2010; 73/106(6): 673–677.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2011 Issue 1
Most read in this issue
- Monitoring of Patients with Severe Head Injury
- Effect of Piracetam, Vinpocetine and Ginkgo Biloba Extract on Antipsychotic-Induced Impairment of Learning and Memory
- Lacosamide (Vimpat®) – a Novel Agent for Add-on Treatment of Focal Epilepsies
- Medication Overuse in Chronic Daily Headache Patients in the Czech Republic